Ingalls & Snyder LLC’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$290K Hold
6,621
0.01% 374
2025
Q4
$294K Hold
6,621
0.01% 374
2025
Q3
$280K Hold
6,621
0.01% 397
2025
Q2
$243K Buy
6,621
+50
+0.8% +$1.86K 0.01% 399
2025
Q1
$250K Hold
6,571
0.01% 389
2024
Q4
$249K Sell
6,571
-1,075
-14% -$43K 0.01% 383
2024
Q3
$311K Hold
7,646
0.01% 363
2024
Q2
$262K Hold
7,646
0.01% 357
2024
Q1
$242K Hold
7,646
0.01% 381
2023
Q4
$234K Hold
7,646
0.01% 377
2023
Q3
$254K Sell
7,646
-250
-3% -$7.99K 0.01% 372
2023
Q2
$242K Hold
7,896
0.01% 379
2023
Q1
$216K Hold
7,896
0.01% 386
2022
Q4
$221K Sell
7,896
-545
-6% -$16.4K 0.01% 388
2022
Q3
$249K Sell
8,441
-276
-3% -$8.65K 0.01% 358
2022
Q2
$246K Sell
8,717
-3
-0% -$85 0.01% 377
2022
Q1
$272K Hold
8,720
0.01% 391
2021
Q4
$258K Sell
8,720
-1,300
-13% -$38K 0.01% 406
2021
Q3
$300K Sell
10,020
-150
-1% -$5.16K 0.01% 383
2021
Q2
$369K Sell
10,170
-35
-0.3% -$1.3K 0.02% 358
2021
Q1
$374K Hold
10,205
0.02% 325
2020
Q4
$371K Sell
10,205
-1,800
-15% -$61K 0.02% 315
2020
Q3
$359K Sell
12,005
-3,100
-21% -$96.8K 0.02% 273
2020
Q2
$449K Sell
15,105
-1,750
-10% -$51.8K 0.03% 268
2020
Q1
$447K Sell
16,855
-1,500
-8% -$56.9K 0.03% 270
2019
Q4
$777K Sell
18,355
-1,000
-5% -$42.3K 0.04% 221
2019
Q3
$809K Sell
19,355
-805
-4% -$31.4K 0.04% 238
2019
Q2
$741K Buy
20,160
+1,000
+5% +$36.5K 0.04% 250
2019
Q1
$731K Hold
19,160
0.03% 243
2018
Q4
$673K Sell
19,160
-13,000
-40% -$451K 0.04% 246
2018
Q3
$1.05M Sell
32,160
-1,000
-3% -$31.8K 0.04% 227
2018
Q2
$1.03M Sell
33,160
-500
-1% -$14.3K 0.05% 203
2018
Q1
$910K Sell
33,660
-8,050
-19% -$215K 0.04% 213
2017
Q4
$1.15M Sell
41,710
-12,200
-23% -$352K 0.05% 197
2017
Q3
$1.72M Sell
53,910
-6,200
-10% -$199K 0.09% 150
2017
Q2
$1.99M Buy
60,110
+4,000
+7% +$132K 0.11% 129
2017
Q1
$1.85M Buy
56,110
+2,774
+5% +$89.1K 0.1% 144
2016
Q4
$1.67M Sell
53,336
-13,950
-21% -$431K 0.09% 151
2016
Q3
$2.38M Buy
67,286
+18,715
+39% +$665K 0.13% 119
2016
Q2
$1.65M Buy
48,571
+7,260
+18% +$242K 0.1% 149
2016
Q1
$1.46M Buy
41,311
+9,900
+32% +$324K 0.09% 143
2015
Q4
$1.1M Sell
31,411
-3,850
-11% -$133K 0.07% 164
2015
Q3
$1.24M Buy
35,261
+1,750
+5% +$61.5K 0.08% 152
2015
Q2
$1.15M Buy
33,511
+11,650
+53% +$428K 0.06% 167
2015
Q1
$886K Buy
21,861
+14,461
+195% +$599K 0.05% 186
2014
Q4
$289K Buy
+7,400
New +$280K 0.02% 295

Other funds holding OHI

Ingalls & Snyder LLC's OHI Position: Q1 2026 in Review

Ingalls & Snyder LLC held its Omega Healthcare (OHI) position steady in Q1 2026 at 6,621 shares worth $290K. The position accounts for 0.01% of the portfolio, ranked #374.

Ingalls & Snyder LLC first reported a position in OHI in Q4 2014 and has held it in 46 quarters since. The position peaked at $2.38M in Q3 2016. 740 funds tracked by Wall St. Rank hold OHI as of Q1 2026.

  • Ingalls & Snyder LLC held 6,621 shares of Omega Healthcare worth $290K as of Q1 2026.
  • Ingalls & Snyder LLC left its Omega Healthcare share count unchanged in Q1 2026.
  • Omega Healthcare made up 0.01% of Ingalls & Snyder LLC's portfolio in Q1 2026, its #374 holding.
  • Ingalls & Snyder LLC first reported a position in Omega Healthcare in Q4 2014 and has held it in 46 quarters since.
  • Ingalls & Snyder LLC's Omega Healthcare position peaked at $2.38M in Q3 2016.
  • 740 funds tracked by Wall St. Rank held Omega Healthcare as of Q1 2026.

Based on Ingalls & Snyder LLC's 13F filing for Q1 2026, filed 13 May 2026.